These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 9563467)
1. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212 [TBL] [Abstract][Full Text] [Related]
4. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Partanen TA; Alitalo K; Miettinen M Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384 [TBL] [Abstract][Full Text] [Related]
5. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800 [TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Kahn HJ; Bailey D; Marks A Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918 [TBL] [Abstract][Full Text] [Related]
8. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Partanen TA; Paavonen K Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969 [TBL] [Abstract][Full Text] [Related]
11. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Irjala H; Alanen K; Grénman R; Heikkilä P; Joensuu H; Jalkanen S Cancer Res; 2003 Aug; 63(15):4671-6. PubMed ID: 12907648 [TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874 [TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. Skobe M; Brown LF; Tognazzi K; Ganju RK; Dezube BJ; Alitalo K; Detmar M J Invest Dermatol; 1999 Dec; 113(6):1047-53. PubMed ID: 10594750 [TBL] [Abstract][Full Text] [Related]
16. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Leu AJ; Berk DA; Lymboussaki A; Alitalo K; Jain RK Cancer Res; 2000 Aug; 60(16):4324-7. PubMed ID: 10969769 [TBL] [Abstract][Full Text] [Related]
17. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121 [TBL] [Abstract][Full Text] [Related]
18. Desmoplakin and Plakoglobin--specific markers of lymphatic vessels in the skin? Fedele C; Berens D; Rautenfeld V; Pabst R Anat Histol Embryol; 2004 Jun; 33(3):168-71. PubMed ID: 15144286 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor as a marker of tumor endothelium. Brekken RA; Huang X; King SW; Thorpe PE Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838 [TBL] [Abstract][Full Text] [Related]
20. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]